James Sondheimer Selected Research

Fibroblast Growth Factor-23

1/2020	Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.
11/2017	Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.
6/2011	Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James Sondheimer Research Topics

Disease

8	Chronic Renal Insufficiency 10/2022 - 06/2011
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 06/2011
4	Kidney Diseases (Kidney Disease) 10/2022 - 01/2019
3	Infections 01/2023 - 01/2020
2	Sepsis (Septicemia) 01/2023 - 01/2020
2	Anemia 07/2020 - 11/2017
1	Vascular Diseases (Vascular Disease) 01/2023
1	Heart Failure 01/2023
1	Stroke (Strokes) 01/2023
1	Uremia 01/2023
1	Myocardial Infarction 01/2023
1	Hypertension (High Blood Pressure) 10/2022
1	Azotemia 10/2022
1	Atherosclerosis 10/2022
1	Cognitive Dysfunction 01/2022
1	Proteinuria 01/2022
1	Cellulitis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Osteomyelitis 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Bacteremia 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Diabetes Mellitus 01/2019
1	Insulin Resistance 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2017
1	Brain Edema (Cerebral Edema) 01/2013
1	Hyperammonemia 01/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
3	Fibroblast Growth Factor-23IBA 01/2020 - 06/2011
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 07/2020 - 11/2017
2	MineralsIBA 01/2020 - 11/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2022
1	PseudouridineIBA 10/2022
1	homocitrullineIBA 10/2022
1	Pyridoxic AcidIBA 01/2022
1	A 17 (A-17)IBA 01/2022
1	cinnamoylglycineIBA 01/2022
1	Kynurenic Acid (Kynurenate)IBA 01/2022
1	tiglylglycineIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	AlbuminsIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	CalciumIBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Parathyroid Hormone (Parathormone)IBA 01/2020
1	Phosphorus (Red Phosphorus)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	AcidsIBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	CreatinineIBA 01/2019
1	LipidsIBA 01/2019
1	Erythropoietin FDA Link 11/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2013
1	EnzymesIBA 01/2013
1	Hormones (Hormone)IBA 06/2011
1	Phosphates (Orthophosphate)IBA 06/2011

Therapy/Procedure

3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023 - 01/2020
1	Renal Dialysis (Hemodialysis) 01/2023
1	Peritoneal Dialysis 01/2023
1	Catheters 01/2023
1	Central Venous Catheters 01/2023
1	Therapeutics 01/2020
1	Continuous Renal Replacement Therapy 01/2013
1	Parenteral Nutrition 01/2013